新氧再“撕”上游供应商：过度控价时代一去不复返

Core Viewpoint - Beijing Xinyang Technology Co., Ltd. (referred to as "Xinyang") has issued a statement in response to recent public criticisms from upstream medical beauty manufacturers regarding its product procurement channels and service capabilities, asserting that these claims are misleading and damaging to its reputation [1][2] Group 1: Company Response - Xinyang emphasizes that all medical devices used are sourced from legally qualified suppliers and are traceable through proper documentation [2] - The company asserts that its chain of clinics operates as legally established medical institutions, with physicians practicing in accordance with the Medical Practitioners Law [2] - Xinyang criticizes upstream manufacturers for prioritizing internal rules over regulatory requirements and consumer rights, stating that these manufacturers have a legal obligation to provide support to compliant medical institutions [2] Group 2: Industry Context - The statement highlights a shift in the medical beauty industry from a market dominated by scarce registration certificates and price control to one characterized by price transparency and fair competition [2] - Xinyang argues that attempts by upstream companies to create a sense of consumer anxiety through terms like "official" and "certified" are detrimental to market dynamics and consumer interests [2]